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e.g. it would have been preferable for the additional databases explored to have 
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to explain why you didn't use additional databases so may need to keep it but 
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We were not entirely sure what the “transition between the scoring and the mnemonic” 
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8. Line 519 - 520, The use of the words "few" and "some" lead your reader to 
judgement. Implicitly few seems like less articles than some to me, as a reader. 
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We have removed the use of “few” and “some” and replaced them with the actual 
numbers.
9. Under section "study authors' outlook on performance" - you could provide 
examples of what a positive and negative outlook were to help the audience 
understand what you classified each way. Consider reviewing examples of "quotes 
for qualitative interviews" 
We have provided one positive and one negative example. However, we are unsure about 
what was meant by “Consider reviewing examples of ‘quotes for qualitative interviews’”.
10. Line 553, you discuss that overwhelmingly reported as poor, but if the framework 
ratings are poor (e.g. "0") can you use them to provide you a valid response. 
The “overwhelmingly reported as poor” quote refers to the authors’ outlook on 
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entirely new or validated versions of older ones. The last sentence of the comment appears 
to be unfinished and we are not unsure about what the reviewer meant to say.
12. Line 669, relies on mnemonic than a clinical, should be mnemonic rather than a 
clinical
We have corrected this.
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Background: Increases in patients seeking advice at pharmacies has led to pharmacy staff 
engaging in diagnostic behaviours. Approaches to diagnosis include using mnemonics and 
clinical reasoning. 
Objectives: The primary aim of this review was to assess the degree to which the criteria 
authors use to evaluate diagnostic performance in pharmacy consultations, in studies that 
use simulated patients or vignettes, conform with a clinical reasoning and a mnemonic 
framework. A secondary aim of the review was to characterise staff performance in the 
studies, based on the authors’ comments of their results.
Methods: MEDLINE, EMBASE and Web of Science were searched between October 2016 and 
April 2017.  Only peer-reviewed studies assessing pharmacy staff’s diagnostic performance by 
using simulated patients or vignettes  were eligible for inclusion. Data were extracted about 
how each study’s criteria conformed with clinical reasoning and mnemonic frameworks. A 
scoring system between 0 and 4 was devised to determine the degree to which studies 
aligned to these two approaches. Risk of bias was assessed using the NHI Study Quality 
Assessment Tools. The review was registered in PROSPERO with identification number 
CRD42017054827.
Results: Sixty-eight studies (55 cross-sectional, 11 educational interventions and 2 RCTs) with 
sample sizes between 10 and 2700 were included in the review. Most studies were of poor or 
fair quality. Performance of pharmacy staff was overwhelmingly reported as poor by study 
authors. This was the case regardless of geography, scenario used or whichever assessment 
framework was utilised. Scrutiny on how authors arrived at these conclusions revealed that 
mnemonic criteria were employed to assess pharmacy staff’s diagnostic performance rather 
than a clinical reasoning approach. 
Conclusions: Potentially important aspects of the decision-making process, that clinical 
reasoning accounts for, were left unexplored. The scope of the number and locations of the 
included studies is a strength of this review, however, the system employed does not 
represent a validated tool. 
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Introduction
In recent decades self-care has been heavily promoted worldwide due to rising health-care 
costs1,2. This move toward patient empowerment has been supported by an increase in 
medicines being available to the public without the need for a prescription3.   Community 
pharmacy staff are ideally placed to facilitate patient self-care and self-medication4-6 and 
indeed, community pharmacies have seen a rise in patients who visit in order to ask for help 
on minor ailments and advice on appropriate medication7. However, community pharmacists 
tend to find accommodating this task particularly challenging7 due to time constraints and 
therefore most consultations are often first conducted by counter staff who do not possess 
the knowledge and experience of pharmacists8,9.
To support pharmacy staff in this role, various protocols and guidelines, often using 
mnemonics, have been widely advocated and adopted, as they are easy to remember and 
quick to implement10. This, in theory, allows standardised questions to be asked, which are 
the same in every consultation and will help gather all the necessary information for a 
diagnosis and an appropriate action to be taken. However, data suggests that these 
standardised methods do not necessarily improve consultation performance11-13, possibly 
because staff may ask questions with no direct relation to the examined conditions and the 
gathered information is not useful for the decision-making process.
In medicine and nursing clinical reasoning processes are extensively used14. Clinical reasoning 
is an evidence-based, dynamic process in which the health professional combines scientific 
knowledge, clinical experience and critical thinking, with existing and newly gathered 
information about the patient. By the end of the process, all available information and logical 
inferences lead to the formation of a diagnosis15-17. This method has the disadvantage of being 
difficult to describe and hard to learn but it has the major advantage of improving clinical 
ability and being an effective method in establishing a diagnosis, possibly because all 
consultation information, either gathered through questioning or examining the patient, 
plays a part in the decision-making. In a community pharmacy context reaching decisions is 
equally pertinent but appears to be poorly described in the literature.  
A previous review 18, examined the rate and type of information gathered during community 
pharmacy consultations (only in developing economies) based on “common themes of the 
types of information that should be included in the information gathering process according 
to the literature”. Besides examining the rate and type of gathered information, however, it 
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is also important to examine their relevance and purpose and how they contribute to the 
decision-making process. It is not known if and to what degree these aspects of a consultation, 
which are related to clinical-reasoning, are performed in pharmacy settings.  .
The primary aim of this review was to assess the degree to which the criteria authors use to 
evaluate diagnostic performance in pharmacy consultations, in studies that use simulated 
patients or vignettes, conform with a clinical reasoning and a mnemonic framework. A 
secondary aim of the review was to characterise staff performance in the studies, based on 
the authors’ comments of their results.
Methods
A protocol for the review was submitted to PROSPERO with identification number 
CRD42017054827 and can be accessed at: 
http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42017054827. 
The inclusion criteria were that the study assessed pharmacy staff diagnostic performance 
and the assessment was described in some form; the pharmacist/pharmacy staff should have 
been presented with and required to have responded to a diagnostic scenario; the scenario 
was presented in the form of simulated patients (SPs) or vignettes. Any study design was 
considered, including cross-sectional studies, interventions and randomised controlled trials. 
Studies needed to be peer-reviewed and published in English; no limit was set on publication 
date. 
Studies were excluded when they did not provide an assessment of performance or a 
description of the assessment; the pharmacist/staff had to deal with an already diagnosed 
condition; they only looked at pharmacists’/staff’s opinions on performance; they asked 
pharmacists/staff to follow specific screening methods or pre-set guidance that would 
prevent the potential use of any critical thinking.
The rationale behind the eligibility criteria was to include any study that had pharmacists and 
pharmacy staff presented with a diagnostic scenario to which they had to respond without 
knowing what the scenario would be and in a setting as close to a real life consultation as 
possible.  A more exhaustive list of inclusion/exclusion criteria was included in the PROSPERO 
protocol, however, only the criteria that were encountered during the selection process are 
mentioned above.
Databases used to identify eligible studies were MEDLINE, EMBASE and Web of Science. Two 
of the authors (VS and PR) performed an initial scoping of the literature using the search 
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algorithm ("community pharmac*") AND ("simulated patients" OR "mystery shopp*" OR 
"secret shopp*" OR "pseudo*" OR vignette*). Originally, we planned to adapt the algorithm 
further, however, more detailed iterations of the algorithm did not improve the search results 
and we eventually decided not to change it. Use of other bibliographic databases, as 
mentioned in the PROSPERO protocol, only provided us with duplicate results to the three 
databases previously mentioned and thus we decided not to use more databases.
Two rounds of searches were carried out. The first one took place on 03-11-2016 and the last 
one on10-4-2017, immediately before the extraction process. During the second round of 
searches, the reference lists of related literature were searched for additional titles. VS and 
PR independently screened the retrieved results titles and abstracts with the third reviewer 
(MG) acting as arbitrator whenever conflicts arose and the same process was followed for full 
text screening. The website platform Covidence was used to facilitate this process. 
Risk of bias analysis was conducted at study level for each included study using the National 
Blood, Heart and Lung Institute’s (NIH) of the U.S. Department of Health and Human Services 
Study Assessment Quality Tools, which rate studies as “good”, “fair” or “poor”. The Quality 
Assessment Tool for Observational Cohort and Cross-Sectional Studies was used for the 
included cross-sectional studies and the Quality Assessment of Controlled Intervention 
Studies tool was used for the included educational interventions and randomised controlled 
trials (RCTs). The analysis was conducted by VS, PR reviewed it and disagreements were 
resolved through discussion.
Data were manually extracted and inserted in to Microsoft Excel by VS and checked for 
accuracy by PR. The extracted data were; study characteristics: publication year, country, type 
of study, participant characteristics, type of results (quantitative or qualitative); quality 
characteristics: reporting of study piloting, SP training, data collection method ; methodology 
characteristics: type of methodology (SPs or vignettes), number of SPs, number of scenarios, 
type of scenarios (symptom presentation or product request), SP role (presenting for 
themselves or someone else); assessment characteristics: how assessment criteria were 
derived, whether studies assessed diagnostic performance in general or focused on the 
diagnosis of a specific condition, which medical conditions were used for  the scenarios, 
whether staff knowledge was assessed and whether studies compared community 
pharmacists’ performance with other pharmacy staff performance. A sub-analysis was 
conducted to establish whether there were differences in the types of conditions that studies 
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of developed and developing economies focused on as this might have been a reason for 
subsequent differences in results between countries of different economic profiles.
Descriptive statistics (total numbers and percentages) were used to report the results.
Data were also extracted about how each study’s criteria conformed with clinical reasoning 
and mnemonic frameworks. To achieve this, both were broken down into 4 characteristics 
(see below) and study texts were qualitatively analysed and coded for passages that 
corresponded to each characteristic. A value of one was assigned for each characteristic 
exhibited, meaning each study could score between 0 and 4. Mode and modal values were 
used to report the results.
These characteristics were developed by VS, after an initial familiarisation with the included 
studies, as summaries of key aspects of clinical reasoning and mnemonic questioning that the 
authors could have reflected on in their studies. The characteristics were reviewed by PR and, 
after discussion, adjustments were made until an agreement was reached. All included 
studies were then searched by VS for passages that indicated whether the authors have 
considered each respective characteristic in the methodology they used, when reporting their 
results or when discussing their results. If that had occurred the study would be awarded one 
point per characteristic, if not it would be awarded no points. The scoring was reviewed by 
PR and disagreements were resolved through discussion.
The characteristics for each framework were the following.
For the clinical reasoning framework:
1. The authors assessed staff against questions with specific relevance to the scenario 
condition (this is to show a basic level of clinical reasoning, even if they don’t explicitly 
mention how or why the questions are relevant) e.g. for an emergency contraception 
scenario staff were expected to ask the question “when was your last menstrual cycle”
2. The authors have mentioned the purpose of the questions they assessed staff against 
(this shows that authors have considered why the questions are asked) e.g. for a 
sleeplessness scenario, patients’ were asked about their medication because it might 
be causing or contributing to the patient’s sleeplessness
3. The authors have reflected on how staff use the gathered information during the 
decision-making process (this is to show that authors have considered the importance 
of information interpretation in some way) e.g. in a dyspepsia scenario, a response to 
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
the question about pain location led the pharmacist to consider indigestion as a 
possibility
4. The authors considered whether there is a connection between the information 
gathered and the final decision taken by staff (to show that information gathering 
should be used for decision-making, even if the decision-making process is not 
described) 
For the mnemonic framework:
1. The authors have assessed staff against questions (regardless of whether they’re 
relevant to the condition or not) e.g. in a common cold scenario staff were expected 
to ask the patient’s age
2. The authors have assessed staff against a checklist of questions they were expected 
to ask e.g. • Check symptoms • Check length of symptoms • Check other medication 
• Check other health condition • Refer if needed • Provide information
3. The authors have explicitly mentioned they used a known mnemonic method, 
guidelines or recommendations to assess performance e.g. WWHAM, WHO 
guidelines, Australian practice? recommendations
4. The authors have reported the final decision staff took  (irrespective of whether it was 
connected to the information gathering or not) e.g. “In 90% of the scenarios not 
appropriate for self- medication, a recommendation was made for the customer to 
see a physician/GP, but in only 30% of those referrals was there sufficient urgency”
Each study was also coded for passages that indicated whether the authors’ outlook on the 
diagnostic performance of the staff assessed in their studies was positive, negative or mixed. 
The results and discussion sections of each study were searched by VS for language that 
indicated whether authors viewed the diagnostic performance of the staff in their studies in 
a positive or negative way or whether they had a mixed reaction, and were coded accordingly. 
The coding was reviewed by PR and revisions were made until consensus was reached.
Results
The database search yielded 732 results, 353 of which were excluded as duplicates.  The titles 
and abstracts of the remaining 379 were screened and 264 of them were excluded. Full text 
screening was performed for 115 studies. From those, 47 studies were excluded based on the 
inclusion/exclusion criteria leaving 68 studies to be included in the review (Figure 1).
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
Study characteristics 
The included studies were published between 1989 and 2017, with the number of studies 
increasing steadily with each passing decade.  The majority of the studies took place in 
Europe, most prominently the UK, Australasia and Eastern Asia. Forty-one of the studies 
originated from developed countries and 27 from developing economic regions (based on UN 
country classification available at www.un.org/development/desa/dpad/wp-
content/uploads/sites/45/publication/2015wesp_full_en.pdf) (Table 1).
Most studies (n=55) employed a cross-sectional study design, however eleven25,29-31,34,35,38-
40,46,70 studies were educational interventions with a before and after design and two37,75 were  
RCTs. Sample size varied widely between studies (10-2700 staff tested); Only 
thirteen27,46,53,56,59,60,64,67,68,71,72,86,87 studies reported on how the sample size was calculated. 
(Appendix) 
In the majority of the studies (n=43), any member of the pharmacy team were the subject of 
investigation. In some cases,21,25,26,33,41,42,50,52,57,72,78 it was not possible to verify staff role, 
either because the researchers stated they were not able to do so, or because the study did 
not make it clear. The terminology used to describe ‘other’ pharmacy staff was divergent and 
often location-specific and it was not always clear to gauge what role they had or the level of 
training/qualification they held. All studies except one55 (purely qualitative) used quantitative 
methods to report their results, although four36,48,79,87 studies did use a combination of 
quantitative and qualitative methods.  (Table 2)
Quality characteristics 
Risk of bias assessment analysis for the cross-sectional studies rated ten21,26,33,41,42,50,52,57,72,78 
to be of poor quality and the other 45 to be of fair quality. As these studies had many things 
in common, in terms of research questions, methodology and outcome measures, the main 
differentiating factor between fair and poor quality was whether they accurately defined their 
study population and between fair and good the fact that no studies assessed their population 
more than once, all studies’ outcome measures were not reliable enough and only one study86 
mentioned that their SPs were blinded to the correct scenario responses.
Assessment for the educational interventions and RCTs found nine studies25,29,30,31,34,35,37, 70,75 
to be of poor quality and four38,39,40,46 to be of fair quality with the main reasons for lowering 
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quality being non-adequate randomisation, not describing adherence to training protocols 
and not reporting the statistical power of their main outcomes as well as that, due to their 
nature, sufficient blinding and training allocation were not possible.
Study piloting was reported to have happened in only 29% (n=20) of studies. Only one34 of the 
educational interventions reported piloting. Despite low levels of reported piloting, most 
(71%, n=44 out of 62) SP studies, did report on the training provided to SPs prior to data 
collection.  In the vast majority of the studies (84%, n=57), data collection forms were 
completed after pharmacy staff interaction. In 18 studies (26%) the use of audio or video 
recording was employed.  Twelve (18%) used both of these methods to be able to verify the 
content of the collection forms.(Appendix)
Methodology characteristics
The most prominent methodology used to assess pharmacist and staff performance was 
through simulated patients; only 5 studies used vignettes,44,47,48,55,62 whilst one80 study used 
both. The number of SPs used in the studies ranged from one to more than 10, however most 
studies employed one or two SPs (n=24). Similarly, the numbers of scenarios used in the 
studies ranged from one to 64, however most used one or two scenarios (n=48). A mixture of 
symptom presentation and product request scenarios (n=38) were most commonly 
employed, although 20 studies solely used symptom presentation scenarios and 6 studies 
were product request scenarios only. In the majority of the scenarios (n=39) the SPs 
presented as themselves and in 19 studies the SP requested advice or product for a third 
person such as a child, relative or a friend. Nine studies used both types of presentation. 
(Appendix) 
Assessment characteristics
Many of the studies (n=29) used published guidelines, recommendations and standards, and 
a further 10 based their assessment on criteria used in other published studies.  Eighteen 
studies stated that the authors had derived their own criteria, whilst 10 studies used ‘expert 
panels’. Eight studies explicitly mentioned basing their criteria on mnemonic acronyms, most 
commonly mentioned of which was WWHAM (Who is the patient, What are the symptoms, 
How long have the symptoms been present, Action taken, Medication being taken). Sixteen 
studies used some form of scoring system for their results (Table 2).
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The majority of studies (n=46) evaluated staff’s performance on specific health conditions 
whilst the remainder (n=22) assessed general diagnostic performance. Sub-analysis of data 
comparing condition with country showed that studies conducted in developed economies 
tended to concentrate on women’s health, such as emergency contraception, and central 
nervous system conditions such as insomnia and headache. Those studies emanating from 
developing economies concentrated on conditions such as diarrhoea and sexually transmitted 
diseases (Appendix). 
Assessment framework ratings
Based on our scoring system, studies tended to have, in total, higher mnemonic 
characteristics in their assessment methods of pharmacy staff’s performance, with a modal 
value of 3 and lower clinical reasoning characteristics with a modal value of 0. Inter-rater 
agreement for the clinical reasoning rating was 80.5% and 82.4% for the mnemonic rating, 
before disagreements were resolved through discussion. There were no great differences in 
modal values between developed and developing economies ratings (clinical reasoning modal 
value of 0 for both, 2 for developing countries’ mnemonic rating and 3 for developed 
countries’ mnemonic rating) or between studies that set out to assess general diagnostic 
performance or a specific condition (clinical reasoning modal value of 0 in both cases,  
mnemonic rating modal value of 3 for general performance and 4 for specific conditions)  . 
For each mnemonic framework characteristic individually, 69% of studies assessed 
performance based on questions not always relevant to scenario condition, 85% used 
checklists, 43% used named mnemonics or guidelines and 74%have reported the final 
decision staff took. For each clinical reasoning framework individually, 53% of studies 
assessed performance based on questions with relevance to the condition at hand, 12% 
reported purposes for the questions asked, 7% reflected on how the gathered information 
was used and 24% considered a connection between the information gathering process and 
the decision-making outcome. 
Study authors’ outlook on performance
Nine of the 68 studies’ authors described pharmacy staff’s performance in positive terms 
(example quote: “Results across all scenarios indicated the provision of a training program […] 
led to a significant improvement in performance30”), whilst 8 described them in mixed terms; 
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the vast majority of authors (n=51) used negative terms (example quote: “assessment and 
counselling provided to such patients were inadequate”63) to describe their results of 
pharmacy staff’s performance. Three of the thirteen educational interventions and RCT 
studies used positive language compared to 6 of the 55 cross-sectional studies. Three of the 
four educational interventions that were assessed to be of fair quality used negative language 
for their results. (Table 5)
Comparisons
Eleven studies included a theoretical assessment of staff’s knowledge (in the form of a 
questionnaire) which was then compared to actual performance through SPs or vignette 
methodology. Seven21-23,35,45,71,86 reported actual performance was worse than the 
performance measured with the questionnaires, one41 study found them to be similar and 
the other two25,39 did not report that information . In the 13 studies that reported 
comparisons between community pharmacists and other staff, nine20,37,43,59,66,67,73,76,83 
reported pharmacists performing better and four21,60,85,86 reported similar performances.
Discussion
Performance of pharmacy staff was overwhelmingly reported as poor by study authors, a 
result which has been reflected in other reviews88. This appeared to be the case regardless of 
geography, scenario used or whichever assessment framework was utilised. Scrutiny on how 
authors arrived at these conclusions revealed that they relied on mnemonic criteria to assess 
pharmacy staff’s diagnostic performance rather than a clinical reasoning approach. This 
means that potentially important aspects of the decision-making process, that clinical 
reasoning accounts for, were left unexplored.
The mnemonic framework provided simple quantifiable results, such as numbers of questions 
asked and the ability then to produce a score, however mnemonic characteristics have been 
called into question in establishing pharmacy staff ability to derive a diagnosis12,13,48. The 
various existing guidelines and well used mnemonics, such as WWHAM (commonly taught in 
UK pharmacy schools), appear to be viewed as appropriate instruments by authors. However, 
to aid a better representation of the actual level of diagnostic staff performance, new tools 
need to be developed, more aligned with a clinical reasoning approach, which would allow 
for the assessment of all parts of the decision-making process. New tools should expand 
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further than measuring the amount of questions being asked based on standardised 
mnemonic methods and examine whether questions being asked by pharmacists and staff 
are based on evidence-based knowledge of the scenarios presented to them, what 
pharmacists or staff want to achieve through their questions and observations and how 
everything relates to their decision-making process and their final decisions. Because these 
concepts are very difficult to be described and examined in quantitative terms, more 
qualitative methods could be employed by researchers, as they could be used in researching 
community pharmacists’ and other staff’s thought process during consultations, identify 
pharmacists’, staff’s and pharmacy students’ needs and attitudes towards improving their 
diagnostic skills, examine the impact of educational interventions on decision-making and 
diagnostic abilities and other potential research topics. Qualitative methodology has been 
underutilised so far, with only four of all included studies in this review using it.
Tools that would be validated, and subsequently more reliable, would help improve the 
overall quality of future studies and avoid risk of bias. Future studies should also take care in 
defining their study populations and having their participants and assessors be blinded to the 
correct scenario responses. Educational interventions aimed at improving diagnosing ability 
in particular, could employ adequate randomisation, include in their results to what extent 
protocols are adhered to, report the statistical power of their results and have a longer length 
and more follow-ups to make sure any positive results can last over time.
Comparisons of pharmacy staff versus pharmacists showed that, on the whole, pharmacists 
performed better. This is to be expected, as pharmacists have more extensive training than 
other pharmacy staff, and this finding favours pharmacists being more visible and proactive 
in undertaking patient consultations rather than leaving this role to less well trained staff9. In 
studies where actual performance was compared to theoretical performance, staff 
performed more poorly in the real-life situation scenarios. This dissonance suggests that 
decision making skills of staff are poorer than they perceive, whereby they possess knowledge 
but do not know how to use it critically. This performance gap is somewhat substantiated 
through the findings of the educational intervention studies, which showed broadly positive 
results (Table 5), although these studies were mostly short-term and of not good quality so 
we cannot draw any firm conclusion about how long these effects may last. However, these 
comparisons were based on very limited numbers of studies and larger reviews would be 
needed to substantiate these findings. 
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Limitations of this review were that it only captured studies published in English and did not 
include any relevant grey literature.  However, it included studies from all over the world and 
its scope was not narrowed to the specific sets of practices and attitudes of any given location. 
The characteristics we developed to code for the clinical reasoning and mnemonic 
frameworks and the coding of the authors’ outlook on their results do not represent a 
validated tool and are instead the review authors’ attempt at establishing a method that 
would allow to study the extent to which these two diagnostic frameworks are used and how 
results are interpreted in the current literature, something that has not thus far been 
attempted in community pharmacy, to the best of our knowledge. By including only studies 
that used simulated patients and vignettes, the benefit is that the included studies 
approximated real-life consultations. The studies included in this review did not allow for 
meta-analysis, but inclusion of diverse studies did allow for a greater variety of data sources 
to be included. 
Conclusion
The current literature assessing pharmacists’ and pharmacy staff’s diagnostic ability via 
simulated patients or vignettes overwhelmingly relies on a mnemonic rather than a clinical 
reasoning framework.  Based on authors’ comments about their results, the common 
perception is that pharmacists’ and staff’s diagnostic ability is poor, regardless of geography, 
diagnostic scenarios or assessment framework. A limited amount of studies found 
pharmacists perform better than other pharmacy staff. The quality of future studies can be 
improved and new tools should be developed for future assessments that go further than 
measuring the amount of questions asked and deeper examine the decision-making process 
during consultations. 
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Table 1 Publication year and country
Criterion Studies References
Year
1989 1 20
1990-1999 6 21,22,23,24,25,26
2000-2009 21 27,28,29,30,31,32,33,34,35,36,37,38,39, 
40,41,42,43,44,45,46,47
2010-2017 40 48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,
65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81
82,83,84,85,86,87
Country
UK 14 13-15,20,22,28,35,36,43,48,51,52,84
Europe 9 27,31,34, 42, 46, 50, 58, 78, 79
Eastern Asia 13 26, 41, 49, 54, 59-61,67,68,72, 80, 83, 86
Western Asia 3 21,73, 63
Northern America 4 24,47,55, 70
Southern America 4 44,56,69,74
Australasia 15 29,30,33, 57,62,64,65,66,75-77,81,82,85,87
Africa 5 32, 40, 45, 53, 71
Transnational 1 25
developing countries 27 21,25,26,32,40, 41,44,45,47,49,53,54,56,59-
61,63,67,68,69,71,72-74,80,83,86
developed countries 41 20,22-24,27-31,33-39,42,43,46,48,50-52,55,60,62,64-
66,70,75-79,81,82,84,85,87
Table 2 Other study characteristics 
Sample 
characteristics
studies references
CPs only 18 22-24, 28,36,44,48,54-56, 58, 62-64, 69-71, 74
Any pharmacy staff 44 20,21,26,27,29-31,33-35,37,38,40-43,46,47,50-52,57,59-61,65-68,
72,73, 75-87
Non-CP staff only 5 25,32,39,45,53
CPs and GPs 1 49
Type of results
Quantitatively 
(descriptive or 
more advanced 
statistics)
67 all studies except 55
Quantitatively 
(using a scoring 
system)
16 24,27,30,34,38,46,58-60,64,68,69,79,81-83
Qualitatively 
(themes)
1 55
Both quantitatively 
and qualitatively
4 36,48,79,87
(CP=Community Pharmacist, GP=General Practitioner)
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Table 3 Assessment criteria basis
Assessment  criteria were decided based 
on:
author derived 18 22,23,31,34,35,43-48,57,72,75,79,82,85
paper 10 49,50,52,62,64-66,69,70,74
standards/guidelines/recommendations 29 25,28-30,32,34,37,39,44,47,51,54,57-61,64,68,
71,75-78,83,84,86,87
WWHAM  protocol 6 37,38,39,42,54,84
WHAT-STOP-GO protocol 1 81
other protocols 1 54
expert panel 10 24,33,36,38,56,62,64,69,84,86
n/a 9 20,21,27,41,45,53,63,73,80
Table 4 Mode score values per characteristic and median values for total scores
characteristic CR1 CR2 CR3 CR4 MN1 MN2 MN3 MN4 Total 
CR
Total 
MN
mode 1 0 0 0 1 1 0 1
median 1 3
(CR=clinical reasoning, MN=mnemonic)
Table 5 Authors outlook on staff's performance results
Authors' outlook on diagnostic performance n reference(*denotes educational 
intervention)
positive 9 28, 29*, 30*, 37*, 46*, 53, 55,65, 66
mixed 8 27, 31*, 58, 62, 70*, 79, 80, 84
negative 51 20-24, 25*, 32, 33, 34*, 35*, 36, 38*, 
39*, 40*, 41-45, 47-52, 54, 56, 57, 59-
61, 63, 64, 67-69, 71-74, 75*, 76-78, 
81-83, 85-87
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Table 6 Types of studies and sample sizes
Type of study Studies References Sample 
size
Studies References
Cross-
sectional
55 20-24, 26-28, 
32,33,36, 41-45, 
47-49, 50-69, 
71-74, 76-87
<100:
101-200:
201-300:
>301:
28
12
8
7
20,22,23,28,32,36,43-45,48,51,52,54-
58,61,64,69,73,74,77,79,81,84,85,87
24,26,42,47,49,62,65,71,76,80,82,86
21,27,41,66-68,72,78
33,50,53,59,60,63,83
Educational 
interventions
11 25, 29-31, 34,35,
38-40, 46, 70
<100:
101-200:
201-300:
>301:
5
2
1
3
31,38,39,40,70
35,46
34
25, 29,30
Randomised 
Controlled 
Trials (RCTs)
2 37, 75 <100:
>301:
1
1
75
37
Table 7 Quality characteristics
Criterion Studies References
Was there a pilot to the 
study reported by the 
authors?
yes 21 22,26,33,34,36,42,44,48-50,54,56,58,62,63,71,76,77,80,82,87
no 47 20,21,23-25,27-32,35,37-41,43,45-47,51-53,55,57,59-61,
64-70, 72-75, 78,79,81,83-86
Did SPs* receive training for 
the study?
yes 54
training mentioned 44 24,25,27-30, 33-41, 45,46,49,52,53,56-60, 65,69, 70,72-87
the SPs had previous 
experience
5 20,42,66,67,68
One or more of the authors 
were SPs
6 26,22,31,43,54,61
external paid service was 
used
1 50
not mentioned 6 21,23,26,32,51,63
How was data captured?
audio/video recorded and 
transcribed
18 28,30,33,34,38,39,42,46,48,55,56,58,65,66,69,74,79,84
data collection form 57 20-27, 30-45,47,51,54, 57-64, 67-87
paid service 1 50
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1420
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1426
1427
1428
1429
1430
1431
1432
1433
1434
1435
1436
1437
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1439
1440
1441
1442
1443
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1447
1448
1449
1450
1451
1452
1453
1454
1455
1456
1457
1458
1459
1460
1461
1462
1463
1464
1465
1466
1467
1468
1469
1470
1471
1472
1473
1474
1475
n/a 3 29,52,53
(SP=Simulated Patient)
Table 8 Methodology characteristics 
Methodology Studies References
SP*s 62 20-43, 45,46, 49-54, 56-61, 63-79, 81-87
vignettes 5 44, 47, 48, 55, 62
both 1 80
Number of SPs
1 13 20,22,23,26,31,36,43,45,54,64,70,87
2 11 24,28,32,42,51,56,57,69,73,75
3 4 21,58,77,78
4 4 52,76,82,86
5 1 41
6 4 27,65,72,81
7 2 70,72
8 1 71
9 1 37
10 4 40,67,80,84
>10 4 33,49,50,63
n/a 12 25,29,30,46,53,60,61,66,68,79,83
Number of Scenarios
1 32 20-23,25,27,35,41-45,48,49,51,52,59,60,64-68,70,71,74,
76,77,80,83,86,87
2 16 26,28,31,32,33,36,46,55,56,57,63,69,73,75,82,85
3 7 30,38,47,50,53,58,72
4 5 24,34,39,78,84
≥5 4 37,62,79,81
n/a 4 21,29,61,40
Type of scenario
Symptom presentation 20 20,21,23,25,26,28,35,36,40,42,43,45,47-49,51,52,65,71,73
Product request 6 46,64,75,77,82,87
both 38 22,24,27,30-34,37-39,41,44,50,53-58,60,62,66-70,72,74,78-
80,83-86
n/a 4 29,59,61,63
SP role
for themselves 32 22,27,28,31-33,36-38,40,45,46,49,56,58-61,63,64,66-68,
70,74-77,80,82,85,87
for someone else (child, 
relative, friend)
19 20,21,23,25,35,41-43,51-54,65,71,78,81,83,84,86
both 9 24,26,34 50,57,69,72,73,79
n/a 3 29,30,39
(SP=simulated patient)
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Table 9 Conditions for general performance assessment or specific condition
Criterion Studies References (*denotes developing country)
Studies assessing diagnostic ability 
of a specific condition 
women's health
Contraceptive management 4 28,57,77,78
 Diseases of the genitourinary 
system  
dysmenorrhoea 1 22
Diseases of the visual system
dry eye 1 51
allergic conjuctivitis 1 52
Diseases of the muscoskeletal 
system 
back pain 1 54*
Diseases of the nervous system
headache 2 58,74*
insomnia 4 59*,64,70,85
serotonin syndrome 1 65
Diseases of the respiratory system
Acute respiratory infection 1 60*
chronic cough 1 76
common cold 1 81
Diseases of the digestive system
peptic ulcer 1 61*
lower bowel symptoms 1 62
GORD 1 66
dyspepsia 1 68*
diarrhoea 9 21*,23, 25*,42, 44*,71*,73*,83*,86*
Conditions related to sexual health
gonnorhoea and genital ulcer 
disease
1 32*
urethral discharge 4 40*, 41*, 45*, 47*
Diseases of the circulatory system
acute cardiac symptoms 1 63*
Neoplasms
oral cancer 3 20,43,59
Certain infectious or parasitic 
diseases
malaria 1 67*
tuberculosis 1 80*
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1552
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1573
1574
1575
1576
1577
1578
1579
1580
1581
1582
1583
1584
1585
1586
1587
1588
1589
1590
1591
1592
1593
Product requests
codeine analgesics 1 82
Antibiotics 1 26*
Criterion Studies References
Studies assessing general diagnostic 
performance using scenarios of
Contraceptive management 1 79
 Certain infectious or parasitic 
diseases
vaginal thrush 2 33,34
Diseases of the visual system
eye discomfort 1 84
Diseases of the muscoskeletal 
system
back pain 1 84
leg cramps/fatigue 1 24
Diseases of the nervous system
headache 4 27,31,36,69*
insomnia 1 55
facial pain 1 56*
Diseases of the respiratory system
Acute respiratory infection 1 53*
allergic rhinitis 1 24
common cold 6 49*,50, 53*, 56*, 79,84,24
Diseases of the digestive system
abdominal pain 1 36
indigestion 1 38
vomiting 1 84
dyspepsia 2 48,79
diarrhoea 4 24,69*,79,84,
Product requests 11 27,31,33,34,38,46,50,53*,72*,78,79
Study evaluated:
General performance 22 24,27,29-31,33,34,36,38,39*,46,48,49*,50,53,55,56*,69*,
72*,78,79,84
Specific condition 46 20,21*-23, 25*, 26*, 28, 32*, 35, 37, 40*, 41*, 42, 43, 44*, 
45*, 47*, 51,52, 54*, 57,58, 59*, 60*, 61*, 62, 63*, 64-66, 
67*, 68*, 70, 71*, 73*, 74*, 80*, 83, 83*, 85, 86*, 87
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Table 10 Clinical reasoning (CR) and mnemonic characteristics scoring for each study
study 
reference CR1 CR2 CR3 CR4 CRTOTAL MN1 MN2 MN3 MN4 MNTOTAL
20 0 0 0 0 0 0 0 0 1 1
21 1 0 0 0 1 0 1 0 1 2
22 1 1 0 0 2 1 1 0 1 3
23 1 0 0 0 1 1 1 0 1 3
24 1 0 0 1 2 0 1 0 0 1
25 1 0 0 0 1 0 1 0 1 2
26 1 0 0 1 2 0 1 0 0 1
27 0 0 0 0 0 1 1 0 1 3
28 1 0 0 0 1 1 1 1 1 4
29 0 0 0 0 0 1 1 1 0 3
30 0 0 0 0 0 1 1 1 0 3
31 0 0 0 0 0 1 1 0 1 3
32 1 0 0 1 2 0 1 1 0 2
33 1 1 0 1 3 0 1 0 0 1
34 0 0 0 0 0 1 1 1 0 3
35 1 0 0 0 1 1 1 0 1 3
36 1 1 1 1 4 0 0 1 0 1
37 1 0 0 0 1 1 1 1 1 4
38 0 0 0 0 0 1 1 1 1 4
39 0 0 0 0 0 1 1 1 1 4
40 1 0 0 1 2 0 1 0 0 1
41 1 0 0 0 1 1 1 0 1 3
42 1 0 0 0 1 1 1 1 1 4
43 0 0 0 0 0 0 0 0 1 1
44 1 0 0 0 1 0 1 1 1 3
45 1 0 0 0 1 0 1 0 1 2
46 0 0 0 0 0 1 1 0 1 3
47 0 0 0 0 0 0 0 0 1 1
48 1 1 1 1 4 0 0 0 0 0
49 1 0 0 1 2 1 1 0 0 2
50 0 0 0 0 0 1 1 0 1 3
51 1 0 0 1 2 1 1 1 0 3
52 1 0 0 1 2 1 1 0 0 2
53 0 0 0 0 0 1 1 0 1 3
54 0 0 0 0 0 1 1 1 1 4
55 1 1 1 1 4 0 0 0 0 0
56 1 0 1 1 3 1 1 0 0 2
57 1 0 0 0 1 1 0 1 1 3
58 0 0 0 0 0 1 1 0 1 3
59 0 0 0 0 0 1 1 1 1 4
60 0 0 0 0 0 1 1 1 1 4
1653
1654
1655
1656
1657
1658
1659
1660
1661
1662
1663
1664
1665
1666
1667
1668
1669
1670
1671
1672
1673
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1676
1677
1678
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1681
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1685
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1691
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1693
1694
1695
1696
1697
1698
1699
1700
1701
1702
1703
1704
1705
1706
1707
1708
1709
1710
1711
61 1 0 0 0 1 1 1 1 1 4
62 1 1 1 1 4 0 0 0 0 0
63 0 0 0 0 0 1 1 1 1 4
64 1 0 0 0 1 1 1 0 1 3
65 1 1 0 1 3 0 1 0 0 1
66 0 0 0 0 0 1 1 0 1 3
67 0 0 0 0 0 1 1 1 1 4
68 0 0 0 0 0 1 1 1 1 4
69 0 0 0 0 0 1 0 0 1 2
70 1 1 0 0 2 1 1 0 1 3
71 1 0 0 1 2 0 1 1 0 2
72 0 0 0 0 0 1 1 0 1 3
73 1 0 0 0 1 1 1 0 1 3
74 0 0 0 0 0 1 1 0 1 3
75 0 0 0 0 0 1 1 0 1 3
76 0 0 0 0 0 1 1 1 1 4
77 1 0 0 0 1 1 1 1 1 4
78 0 0 0 0 0 1 1 1 1 4
79 0 0 0 0 0 1 1 0 1 3
80 0 0 0 0 0 0 0 0 1 1
81 0 0 0 0 0 1 1 1 1 4
82 0 0 0 0 0 1 1 1 1 4
83 0 0 0 0 0 1 1 1 1 4
84 1 0 0 0 1 1 1 1 1 4
85 1 0 0 0 1 1 1 1 1 4
86 1 0 0 1 2 0 1 0 1 2
87 1 0 0 0 1 0 1 0 1 2
MODE 1 0 0 0 1 1 0 1
MEDIAN 1 3
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1722
1723
1724
1725
1726
1727
1728
1729
1730
1731
1732
1733
1734
1735
1736
1737
1738
1739
1740
1741
1742
1743
1744
1745
1746
1747
1748
1749
1750
1751
1752
1753
1754
1755
1756
1757
1758
1759
1760
1761
1762
1763
1764
1765
1766
1767
1768
1769
1770
